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Abstract
Myocardial infarction in young female is rare condition, but carries signifi cant morbidity and mortality. 
The recognition management for MI in young female is challenging due to its unspecifi c clinical 
presentation and lack of guidance in the current guidelines. We reported a 29-years old woman 
presenting with infarction type chest pain, showing ST- elevation in the inferior leads with total AV 
block as complication. The risk factors in this patient were smoking, family history, cardiomyopathy, 
and preeclampsia history. The cause for myocardial infarction in this patient was atherosclerotic 
plaque rupture, but we did not manage to performed coronary intervention due to her low ventricular 
function and unavailability data for myocardial viability at the time of hospitalization.
Introduction
ST elevation myocardial Infarction (STEMI) 
still represents the leading cause of mortality 
and morbidity in the worldwide and is also very 
important in women as a cause of death and 
disability. Most coronary heart disease is found in 
the older age groups, but it also occurs in younger 
people, with a lower prevalence in women than 
men. Fortunately, its incidence is not common 
in patients younger than 45 years. However, 
the disease carries a significant morbidity, 
psychological effects, and fi nancial constraints for 
the person and the family when it occurs at a young 
age especially women. Previously the MI in young 
female was ignored since women carry protective 
factors, but recently available data showed the 
incidence has signifi cant mortality in this group 
(Vaccarino et al., 2000). This problem of MI in such 
young age group became substantial since they 
are in the productive age and provide signifi cant 
contribution to the community. Several studies 
has reported clinical profi le and the outcome of 
STEMI in young age, with variable incidence 
2-10% (Wong et al., 2012). 
It has not been clear yet whether the 
incidence of MI in young female is associated with 
prognosis or requires further management which 
is different to those older. In addiation, whether MI 
in young female in a representation of infarction or 
an acceleration process of atherosclerosis as in 
older population still remain questioned. However, 
primary and secondary prevention has defi nitely to 
be performed intensively to such young population 
(Alkhiary, 2011). The clinical presentation and 
risk factors of MI in young female are different 
and often cause the ignorance of this population 
in epidemiological research and clinical trials. 
In the database Get with the Guidelines CAD, it 
was found that the mortality rate due to STEMI 
in woman is twice higher and in this population 
women received lower aspirin and beta blocker as 
compared to men. In addition, there was smaller 
number of reperfusion therapy in this population 
and the reperfusion time is delayed (Wenger, 
2012). 
A small number of studies in women with MI, 
the lack of participant in clinical trials have caused 
discrepancy in the symptom recognition, acute 
management and long term treatment for women 
with STEMI as compared to men. However, 
guideline from American Heart Association 
on cardiovascular disease in women pointed 
important message on the prevention and several 
consideration on pregnancy, gestational diabetes, 
and hypertension in pregnancy as a risk factor 
for cardiovascular in women (Wenger, 2012). 
In this report, we presented a young female, 5 
months post delivery who suffered from STEMI. 
Important message to be discussed in this 
report are incidence, risk factors associated with 
atherosclerosis, management, and prognosis. 
 
Case
A 29 years-old female came to the emergency 
department of our hospital reffered by rural hospital 
with infarction type chest pain 3 days before 
admission. The pain was dull, heavy, retrosternal 
radiating to the back accompanied by diaphoresis 
and nausea. At the rural hospital she had been 
admitted for 2 days as having myocardial infarction 
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and she was reffered due to history of total AV block. 
There was no previous complain of angina at all. 
Five months before admission, she was 
diagnosed as having congestive heart failure due 
to peripartum cardiomyopathy. This abnormal 
LV function has limited her for household work 
due to dyspnea on effort. She had 3 histories of 
pregnancy and delivery. There was no history of 
abortion. The fi rst two deliveries were normal, 
while the last delivery mode was cesarean section. 
She denied any history of using neither hormonal 
nor mechanical contraception. The atherosclerotic 
risk factors for this patient were smoking for the 
last 10 years, 10 cigarettes per day and the strong 
family history of the father died of having heart 
attack at 45 years old. In addition, she had history 
of pre-eclampsia and peripartum cardiomyopathy 
(PPCM). There was no history for sing and 
symptoms related to autoimmune diseases. 
Physical examination on arrival showed that 
the patient was dyspnea with stable hemodynamic 
signs; BP 110/70 mmHg, pulse 92x/minute, 
respiration rate 24x/minute, and SpO2 99%. 
There was increase in jugular vein pressure and 
enlargement of the heart with gallop S3. We did 
not fi nd any murmur or other heart sound. Lung 
examination was normal, we found ascites and 
enlargement of the liver. There was no abnormality 
in the extremities. Chest X-ray revealed a 
lateral downward apex of the heart showing the 
enlargement of the LV. There was also sign of LA 
and RV enlargement (Figure 1). 
ECG examination showed sinus rhythm, 
total AV block with ventricular rate 40x/minute 
and evoluted ST elevation in the inferior leads (II, 
III, dan avF). In our hospital, there rhythm was 
sinus with evoluted ST elevation in inferior leads 
accompanied by reciprocal ST depression in I and 
aVL, as well as the signs of LVH and LAH. 
Laboratory examination showed increase 
in the cardiac enzyme; CK 2746; CKMB 623; 
Trop I 9,57. Due the suspicion of vasculitis, we 
performed an erythrocyte sedimentation rate and 
CRP level. The ESR was normal while the CRP 
showed positive result 10 mg/L. However due to 
its high value, we consider that this was a result 
of coronary thrombosis and myocardial infarction 
rather than vasculitis. Based on the data above, we 
diagnosed this patient as STEMI inferior with the 
suspicion of non atherosclerotic cause probable 
hypercoagulable state or vasospastic. 
Echocardiography examination showed 
dilated all cardiac chambers with dyskinesis in 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. ECG examination in rural hospital (left) and in our hospital (right).
Figure 1. Chest X-ray showed enlargement of the 
cardiac chambers 
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anteroseptal and hypokinesis in other segments 
of the wall. The left ventricular end diastolic 
diameter (LVIDd) was 52.4 mm and the EF was 14 
– 20%. There was also decreased in RV function 
with Tricuspid Annular Plane Systolic Excursion 
(TAPSE) 6 mm. We also found mitral and tricuspid 
regurgitation due to chamber dilatation.  
 We then performed coronary angiography 
and showed 70% long stenosis in the right 
coronary artery (RCA) from proximal to mid 
segment. In addition in the proximal we found a 
90% stenosis with suspicion of soft plaque. The left 
anterior descenden (LAD) and left circumfl ex (LCx) 
still within normal limit (Figure 3). We decided not 
to perform coronary intervention directly due to 
its reduced systolic function, thus the myocardial 
viability was necessary. 
We admitted the patient in the ICCU and 
we administered unfractionated heparin (UFH) 
in addition to aspirin 1x80 mg, clopidogrel 1x75 
mg, simvastatin 1x20 mg and the medication for 
heart low LV function which are captopril 3x25 
mg and furosemide. On the day 5, we added 
carvedilol 1x3.125 mg as heart failure treatment. 
During her admission, she once suffered from a 
frequent ventricular extra systole (VES) which was 
improved with lidocaine therapy. 
Patient was admitted for 7 days, and 
discharged after adequate mobilization and 
cardiac rehabilitation without any symptoms and 
signs of ischemia. The definite diagnosis was 
STEMI due to atherosclerotic plaque rupture and 
PPCM, and we managed her with aspirin 1x80 
mg, clopidogrel 1x75 mg, simvastatin 1x20 mg, 
furosemid 40 mg/hari, carvedilol 1x 3.125 mg, and 
captopril 3x 25 mg. 
Discussion 
In our case we reported a 29 years-old 
female in the productive age who suffered from 
STEMI due to atherosclerotic plaque rupture. 
The interesting point in this case was that MI 
occurred in young female, in her reproductive age, 
  
Figure 3.  Coronary angiography showed 70% long stenosis in RCA (upper) 
and soft plaque (arrow). LCx (lower left) and LAD (lower right) were 
normal. 
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5 months after delivery. There were many reports 
regarding the MI in young age, however the cases 
in young female were rarely published. A case 
report showed a 25-years old female with high 
risk factors of smoking and metabolic syndrome 
suffered from STEMI (Falcone et al., 2004). A study 
in 303 young women aged less than 40 years 
old, showed 5% incidence of MI in less that 25 
years old. In this study, 22 out of 32 patients were 
screened for coronary heart disease and showed 
ECG revealing old myocardial infarction (Arnold 
dan Moodie, 1993). 
In young female, the combination for risk 
factors hold important role for MI. In our case, 
the patient smokes, had strong family history, 
PPCM as well as pre-eclampsia history in the 
last pregnancy. The combination for risk factors 
increases the incidence of MI. One study showed 
that in women less than 30 years old who suffer 
from MI, 60% has hypercholesterolemia, increase 
LDL, and triglyceride. In addition, 28% had juvenile 
diabetes, 38% had hypertension, and 28% used 
oral contraception (Arnold dan Moodie, 1993). 
Seventy two percent young female who had MI 
is smoker. Thus, smoker is the strong risk factors 
for MI in young female. Based on Myocardial 
Infarction Causality (MICA), smoker women had 
10 times odd ratio to have MI. The increase in the 
number of cigarette per day, the bigger risk they 
have. Smoking is known to decrease estrogen in 
women, thus pre menopause women had risk of 
MI with smoking (Dunn et al., 1999).
Family history hold important role and 
positively associated with early MI in women. In 
study who enrolled women with MI aged 18-40 
years, family risk factors contribute to 5.17 times 
odd ratio (Friedlander et al., 2001).  Our patient 
had strong family risk factor on the father. The role 
of traditional risk factors for MI in young age is 
lower as compared to those who is older. However, 
non traditional risk factors such as infl ammatory 
gen, homosistein level, as well as intima-media 
thickness (IMT) shared important risk (Knofl ach 
et al., 2009). In our patient, unfortunately we did 
not measure the factors above. 
Among reproductive factors, the association 
between coronary heart disease and parity 
showed inconsistent data. Some data showed 
that the parity number is associated with coronary 
heart disease, some is not. Young age at the 
fi rst delivery has been reported to be associated 
with the increase in risk. In addition, women who 
have history of spontaneous abortion also have 
increase risk for MI as compared to those who do 
not (Bertuccio et al., 2007). These also account 
for the history of pre-eclampsia and PPCM (Lin et 
al., 2011). It was reported that C-reactive protein 
(CRP), Tumor Necrosis Factor (TNF)-α in both 
diseases (Fett dan Ansari, 2010). The estrogen 
level in women is known to have protective 
effect against MI. The reduced estrogen level in 
menopause women increases risk for MI in that 
population. Estrogen defi ciency in pre menopause 
women will increase 7 times for the risk of MI 
(Anderson dan Pepine, 2007). In our patient we 
did not measured the estrogen level due to some 
limitation on the laboratory examination. 
The variability of clinical presentation for MI 
in young female is challenging for doctors. The 
initial presentation is not specific and unclear. 
Infarction type chest pain is rarely signifi cant. About 
85 – 90% women showed prodromal symptoms 
prior to MI, however most of the patients ignore 
these symptoms. Unfortunately, some who seek 
for medical advice due to these symptoms reported 
unawareness from medical professional thus often 
misdiagnosed (Mcsweeney et al., 2003). Several 
studies in women reported only 29.7% patients 
suffer from chest pain. The characteristic for chest 
pain in women varied from heavy, feeling numbness, 
burned, feeling fullness, even tickling. Other acute 
symptoms are breathless (58%), weakness (55%), 
fatigue (43%), cold sweating (39%), and headache 
(39%). The pain usually radiates to the back (37%) 
and shoulder (28%) (Mcsweeney et al., 2003). 
MI in young female had coronary characteristic 
varied from traditional atherosclerotic process 
to secondary due to other underlying disease. 
This pattern should be evaluated by coronary 
angiography. Morphologically, the coronary size 
in women is smaller as compared to men, even 
after adjusted with body weight. Aortic stiffness 
associated with age is more frequently found 
in diabetic women. This change also occurs in 
pregnancy, and may refpect some physiological 
changes. However, the stiffness is a pathological 
manifestation of vascular remodeling that should 
not be ignored (Anderson dan Pepine, 2007). 
Women who suffer from atherosclerotic plaque 
rupture showed different coronary characteristics. 
It was reported that 44% had single-vessels, 44% 
had multivessel disease and 13% had normal 
coronary vessel (Glover et al., 1982). Our patient 
showed soft plaque in proximal RCA. 
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The clinical implication of MI in young female 
is to defi ne the best therapeutic band intervention 
strategy. Previous study reported that men are 
more likely to receive thrombolysis, aspirin and 
beta blocker as compared to women, indicated that 
the standard strategy accordingn to guidelines has 
not been well implemented in women. Percutaneus 
intervention in women has been reported 14.2% as 
compared to 24.4% in men. The expected number 
of intervention in women is 17.4% (Anderson dan 
Pepine, 2007). The under-treatment condition 
in women given the high risk factors profi le has 
increase mortality. In our case, we administered 
dual antiplatelet therapy and statin. We did not 
performe coronary intervention in our patient 
during hospitalization due to lack of myocardial 
viability data. 
The differences in comorbodity among 
gender result in different outcome after MI. 
Several conditions are diabetes, post delivery 
state that including peripartum vascular diseaction, 
preeclampsia and eclampsia, polycystic ovarian 
syndrome, and low birth weighted baby (Anderson 
dan Pepine, 2007). Another study showed that 
female gender is an independent predictor for short 
term outcome after MI. In addition, the negative 
outcome in women post MI will increase in younger 
age. As compared men with similar age, young 
female had 25% higher mortality and this ratio will 
decrease with the increment of age (Andrikopoulos 
et al., 2006). 
Conclusion
We reported a 29 years-old female with 
inferior STEMI occurring 5 months after delivery. 
Although she was considered protected by 
estrogen mechanism, the other risk factors for 
MI in this patient was smoker and strong family 
history.  The suspicion for MI in younger age should 
be increased especially for those who has strong 
risk factors. The careful examination should be 
performed to prevent misdiagnosis. Aggressive 
therapy and the guideline implementation must be 
adjusted similarly to women as to men to decrease 
mortality and negative outcome after MI. 
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